Company Number: 14627658

Analysis Date: 2025-07-20 14:08 UTC

Financial Health Assessment of MIGDAL LIMITED

---

1. Financial Health Score: D

Explanation:
The company is currently classified as dormant with minimal financial activity and extremely limited financial resources (£2 cash and net assets). While there are no overdue filings or signs of distress, the financial data reflects a very early stage or inactive operational status, which carries risk if the company intends to trade without further capital injection or operational activity.

---

2. Key Vital Signs

Metric	Value	Interpretation
Status	Active	Company is registered and operationally "live" but dormant in terms of trading activity.
Account Category	Dormant	No significant financial transactions during the year; minimal financial records.
Cash	£2	Extremely low liquidity; essentially no operating cash flow or working capital.
Net Assets / Shareholders Funds	£2	Minimal equity base; company has not accumulated assets or retained earnings.
Filing Compliance	Up to date	No overdue accounts or confirmation statements; good administrative health.
Industry SIC Code	68100	Engaged in buying and selling own real estate, but no active trading reflected yet.
Directors	2 (both active)	Directors appointed and managing, with no reported misconduct or disqualification.
People with Significant Control	Two individuals each owning 25-50%	Shareholding and control distributed between the two directors.

---

3. Diagnosis: Financial Symptoms and Underlying Business Health

• Dormant Status & Minimal Financial Activity: The company has declared itself dormant for the financial period ending 31 January 2024, meaning it recorded no trading activity or significant financial transactions. This is typical for a newly incorporated entity yet to commence operations or a company in voluntary inactivity.

• Insufficient Working Capital: With only £2 in cash and net assets, there is no working capital cushion to fund any operational activities, investments, or unexpected expenses. This is a symptom of a "starving patient" financially, requiring infusion of capital or assets to become viable.

• No Revenues or Profits: Absence of profit and loss data indicates no trading revenue or expenses. This limits the ability to assess profitability or operational efficiency.

• Healthy Regulatory Compliance: Up-to-date filings and no overdue returns show good governance practice, reducing risk of penalties or forced dissolution.

• Ownership and Control: Two directors/shareholders hold substantial control, which could facilitate quick decision-making but also concentrates risk.

---

4. Prognosis: Future Financial Outlook

• Short Term: Without capital injection or commencement of trading, the company will likely continue to show dormant status with negligible financial activity. This is stable but not sustainable for growth.

• Medium to Long Term: To transition from dormancy to a healthy operating business, MIGDAL LIMITED must secure funding (equity or debt), develop operational cash flow, and build working capital to meet liabilities and invest in real estate activities aligned with its SIC code (buying and selling own real estate).

• Risks: Prolonged dormancy can erode stakeholder confidence and might lead to administrative closure if the company fails to demonstrate activity or growth.

---

5. Recommendations: Prescription for Financial Wellness

• Capital Injection: Directors/shareholders should consider contributing additional funds or assets to build a cash buffer that supports initial trading activities.

• Operational Kick-Start: Develop a clear business plan to initiate buying and selling of real estate assets, generating revenue and operational cash flow.

• Financial Monitoring: Establish regular financial reporting and budgeting processes to monitor cash flow, working capital, and profitability once trading starts.

• Maintain Compliance: Continue timely filing of accounts and confirmation statements to avoid penalties and maintain good corporate standing.

• Risk Management: Assess potential liabilities and ensure adequate insurance and legal frameworks are in place as operations commence.

---

Medical Analogy Summary

MIGDAL LIMITED currently resembles a patient in a state of dormancy—like a patient resting to recover but with very minimal vital signs (cash and assets). While there are no immediate symptoms of distress such as overdue filings or insolvency, the company’s financial pulse is weak and requires nourishment (capital and trade activity) to awaken into a healthy, thriving business.

---